Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 6
2003 10
2004 10
2005 14
2006 12
2007 6
2008 8
2009 8
2010 6
2011 11
2012 6
2013 6
2014 1
2015 1
2016 2
2017 4
2018 5
2019 7
2020 14
2021 14
2022 15
2023 18

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Adeleke M, Vickerstaff V, Ambler G, Hunter R, Bunce C, Nathwani N, Barton K; LiGHT Trial Study Group. Gazzard G, et al. Ophthalmology. 2023 Feb;130(2):139-151. doi: 10.1016/j.ophtha.2022.09.009. Epub 2022 Sep 17. Ophthalmology. 2023. PMID: 36122660 Free article. Clinical Trial.
Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma: An Overview of Cochrane Systematic Reviews and Network Meta-analysis.
Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, Hu K, Jayaram H, King A, Otárola F, Nikita E, Shah A, Stead R, Tóth M, Li T. Bicket AK, et al. Among authors: gazzard g. JAMA Ophthalmol. 2021 Sep 1;139(9):983-989. doi: 10.1001/jamaophthalmol.2021.2351. JAMA Ophthalmol. 2021. PMID: 34264292 Free PMC article. Review.
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M; LiGHT Trial Study Group. Gazzard G, et al. Lancet. 2019 Apr 13;393(10180):1505-1516. doi: 10.1016/S0140-6736(18)32213-X. Epub 2019 Mar 9. Lancet. 2019. PMID: 30862377 Free PMC article. Clinical Trial.
Glaucoma: now and beyond.
Jayaram H, Kolko M, Friedman DS, Gazzard G. Jayaram H, et al. Among authors: gazzard g. Lancet. 2023 Nov 11;402(10414):1788-1801. doi: 10.1016/S0140-6736(23)01289-8. Epub 2023 Sep 21. Lancet. 2023. PMID: 37742700 Review.
June consultation #6.
Gazzard G. Gazzard G. J Cataract Refract Surg. 2020 Jun;46(6):925-926. doi: 10.1097/01.j.jcrs.0000681836.35111.ea. J Cataract Refract Surg. 2020. PMID: 32541415 No abstract available.
Clinical risk stratification in glaucoma.
Poostchi A, Kastner A, Konstantakopoulou E, Gazzard G, Jayaram H. Poostchi A, et al. Among authors: gazzard g. Eye (Lond). 2023 Oct;37(15):3121-3127. doi: 10.1038/s41433-023-02480-5. Epub 2023 Mar 14. Eye (Lond). 2023. PMID: 36918628 Free PMC article. Review.
Prevention of angle-closure glaucoma: balancing risk and benefit.
Foster PJ, Ng WS, Nolan WP, Tanner L, Gazzard G, Day AC, Sanders R, Foot B, Salmon JF, Azuara-Blanco A. Foster PJ, et al. Among authors: gazzard g. Eye (Lond). 2022 Dec;36(12):2229-2231. doi: 10.1038/s41433-021-01881-8. Epub 2022 Jun 20. Eye (Lond). 2022. PMID: 35725765 Free PMC article. No abstract available.
163 results